Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifl uorophenylamino)-9H-purin-2-ylamino]-cycl ohexan-1-ol, compositions thereof, and use therewith

Details for Australian Patent Application No. 2007318132 (hide)

Owner Signal Pharmaceuticals, LLC

Inventors Beauchamps, Marie G.; Hilgraf, Robert; Kothare, Mohit Atul

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007318132

PCT Pub. Number WO2008/057252

Priority 60/854,757 27.10.06 US

Filing date 26 October 2007

Wipo publication date 15 May 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/057252 Priority application(s): WO2008/057252

23 July 2009 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to include co-inventors Cameron, Louise Michelle; Saidane, Monohar T. and Xu, Jean

27 August 2009 Amendment Made

  The nature of the amendment is: Amend the name of the coinventor to read from Saidane, Monohar T. to Saindane, Monohar T.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007318141-Surgical articles for treating pelvic conditions

2007318121-Method for forming a slider reclosure segment